エピソード

  • Should Teenagers Take Ozempic? - Growing Up on a Lifelong Drug

    Should Teenagers Take Ozempic? - Growing Up on a Lifelong Drug
    2026/04/07
    Olivia Harper examines prescribing Ozempic and weight-loss drugs to adolescents as young as twelve, exploring informed consent challenges, unknown long-term effects on developing bodies and brains, mental health risks including suicidal ideation, and the tension between treating severe obesity versus cultural pressures.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    続きを読む 一部表示
    28 分
  • Should Teenagers Take Ozempic? - The Pediatricians' Dilemma

    Should Teenagers Take Ozempic? - The Pediatricians' Dilemma
    2026/04/07
    Miss Olivia Harper explores the agonizing choices pediatricians face when prescribing weight-loss drugs like Wegovy and Ozempic to severely obese adolescents. She examines FDA approvals, supply shortages, off-label use, long-term unknowns about growing bodies, and the systemic inequities fueling childhood obesity—revealing why this medical debate has no easy answers.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    続きを読む 一部表示
    26 分
  • Should Teenagers Take Ozempic? - What the Science Actually Says

    Should Teenagers Take Ozempic? - What the Science Actually Says
    2026/04/07
    Miss Olivia Harper examines the science behind FDA-approved weight loss drugs like Wegovy for adolescents aged 12-17 with obesity. We cover clinical trial data showing 5-17% BMI reductions, concerns about long-term effects on developing bodies, the AAP's landmark 2023 guidelines, surging prescription rates including off-label Ozempic use, and why systemic factors matter as much as medication.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    続きを読む 一部表示
    26 分